Related Experiment Videos
[Isolated increase in the bleeding time: the hemorrhagic risk and therapeutic problems]
Annales Francaises D'Anesthesie Et De Reanimation
|January 1, 1986
Summary
An isolated increase in bleeding time is rare but can pose surgical risks, especially with co-existing hemostatic defects. Careful surgical management and avoidance of certain drugs are crucial for patient safety.
Area of Science:
- Hematology
- Surgical Hemostasis
Background:
- Isolated increases in bleeding time are uncommon.
- Bleeding disorders may present in youth (e.g., epistaxis) or pose surgical risks in middle age.
- Certain medications can exacerbate bleeding time.
Observation:
- The principle that one hemostatic defect is often well tolerated, whereas two are not, is clinically significant.
- Patients with increased bleeding time require meticulous surgical management.
- Specific drugs known to increase bleeding time should be avoided.
Findings:
- Careful surgical hemostasis management enables many patients with bleeding defects to undergo surgery safely.
- While treatments like steroids and desmopressin acetate (DDAVP) exist, their routine use is not recommended.
Implications:
- Highlights the importance of pre-operative assessment for bleeding disorders.
- Emphasizes the critical role of meticulous surgical technique in managing patients with hemostatic defects.
- Suggests a conservative approach to pharmacological intervention for bleeding time abnormalities during surgery.